Breaking News
March 24, 2019 - Hidden differences between pathology of CTE and Alzheimer’s disease discovered
March 24, 2019 - Knowing causative genes of osteoporosis may open door to more effective treatments
March 24, 2019 - Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
March 24, 2019 - New model for intensive care identifies factors that send ill patients to ICU
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
New discovery may lead to better treatment options for pancreatic cancer patients

New discovery may lead to better treatment options for pancreatic cancer patients

image_pdfDownload PDFimage_print

Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center – Jefferson Health and Lankenau Institute for Medical Research scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer. The discovery may help physicians provide better treatment options for patients.

“The findings could point to a therapeutic target or an important prognostic biomarker,” said George Prendergast, PhD, President and CEO of the Lankenau Institute for Medical Research (LIMR) of Main Line Health who co-led the study with Jonathan Brody, PhD, Director of the Research Division and Professor of Surgery at Thomas Jefferson University, both of whom are members of the Sidney Kimmel Cancer Center — Jefferson Health.

The team published the new work September 28 in the journal Clinical Cancer Research.

The IDO2 gene, which was first discovered by LIMR researchers in 2006, produces an enzyme that helps manage the immune system. During pregnancy, IDO2 and a related gene, IDO1, tone down the mother’s immune system so it will not attack the fetus, for example. Cancer, however, hijacks the IDO genes’ function. It uses IDO1 and 2 to conceal itself from the immune system. The researchers thought that shutting down the IDO enzymes could make the cancer visible to the immune system, thereby allowing the body’s defenses the opportunity to fight the cancer. In fact, in previous research, the team found that mice lacking the IDO genes did not develop pancreatic cancer in a rodent model of the disease. The results suggested IDO genes are essential to pancreatic cancer progression.

Now, Drs. Brody and Prendergast find IDO2 spurs the formation of PDAC tumors. When the researchers induced the development of pancreatic cancer in mice, they found nearly 30 percent of rodents developed the invasive cancer. In mice that lack the IDO2 gene, however, the cancer grew in only 15 percent of the animals. Strikingly, all the mice lacking IDO2 that developed cancer were male. The results suggest IDO2’s involvement in pancreatic cancer may affect females differently from males.

The researchers knew that many people in the general population have inherited, or germline, alterations in the IDO2 gene that turn off the gene’s ability to mediate the immune system. So the scientists examined the IDO2 gene in a subgroup of pancreatic cancer patients from Thomas Jefferson University Hospital. Genetic testing is easy and cost effective, since researchers need only a sample of blood or cheek swab to detect this DNA.

“Besides IDO2’s involvement in development of pancreatic cancer, we wanted to know whether IDO2 affects how patients respond to treatment,” said Dr. Brody.

When the team compared patients’ IDO2 genes with their prognosis, they found that patients with defunct IDO2 genes had more favorable outcomes.

“The patients in our small cohort actually do better in specific treatment settings,” said Dr. Brody. “They have improved disease-free survival when they receive radiotherapy.”

Patients with nonfunctional IDO2 who also received adjuvant radiation treatment lived cancer-free for almost twice as long as patients with a working version of the gene, the researchers found. The results suggest that people with a specific IDO2 gene status may respond better to radiotherapy for their disease. In fact, patients who had deficient IDO2 gene status and received radiotherapy had a markedly improved survival. Patients with a functioning IDO2 gene who had received radiation treatment did not demonstrate such benefits and nor did patients with an inactive IDO2 gene who did not receive radiotherapy.

Together, these initial findings suggest that IDO2 gene status has the potential to influence pancreatic care decision-making (i.e., precision therapy). In the future, physicians may be able to use the gene’s status as a biomarker to inform their treatment recommendations.

“Developing new strategies to refine therapeutic options has been a top priority of our nationally recognized pancreatic cancer team at the Sidney Kimmel Cancer Center,” says cancer researcher Karen Knudsen, PhD, Director of the Sidney Kimmel Cancer Center – Jefferson Health. “This breakthrough in understanding lays the foundation for determining what patients might most benefit from radiotherapy, and represents a major step forward toward the goal of precision oncology.”

Although the researchers are excited about these findings, Dr. Brody suggests a lot of work needs to be done to validate the study in additional, larger cohorts, and ultimately, in a prospective clinical trial. If confirmed, Brody states, “With a simple blood test, physicians could determine a patient’s IDO2 gene status and determine whether they should go on radiotherapy.”

Source:

https://www.jefferson.edu/

Tagged with:

About author

Related Articles